MedPath

Effectiveness of App-based Relaxation for Patients With Chronic Low Back Pain (Relaxback)

Not Applicable
Terminated
Conditions
Chronic Low Back Pain
Interventions
Behavioral: Relaxation exercise
Other: ususal care
Registration Number
NCT02019498
Lead Sponsor
Charite University, Berlin, Germany
Brief Summary

The aim of the pragmatic randomized study is to evaluate whether additional relaxation technique is more effective in the reduction of chronic low back pain compared to usual care alone.

Detailed Description

Objective: To evaluate whether additional relaxation technique is more effective in the reduction of chronic low back pain compared to usual care alone.

Study design: Open single-centered randomized two-armed pragmatic trial.

Participants: 220 patients aged 18-65 years with chronic (\>12 weeks) low back pain and a mean pain score ≥ 4 on a Numeric Rating scale (NRS) in the last week before randomization who will be randomly allocated to two groups (relaxation, usual care alone as waiting list)

Intervention: Participants apply either a daily 15-minute relaxation exercise guided by a smartphone application ("app"). or apply no additional intervention. The exercise should be applied daily, (minimally five days per week) for 6 months. The app contains audios to guide autogenic training, muscle relaxation training and guided imagery. On a daily basis, participants can select one of the three exercises which they want to apply.

Main outcome measure: The primary outcome is the mean pain intensity after 3 months measured by the daily pain intensity on the NRS.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • female or male
  • 18-65 years of age
  • chronic low back pain for at least 12 weeks
  • if additional back pain is reported, low back pain has to be predominant
  • intensity of the average low back pain ≥ 4 on the numeric rating scale (NRS) in the last week
  • presence of a smartphone (iphone, Android phone) and willingness to do data entry through a smart phone application (App)
  • willingness to be randomized, to apply study intervention according to the protocol, to complete the baseline questionnaire in paper form and electronic questionnaires and diaries provided by an App physical and mental ability to participate in the study
  • written and oral informed consent
Exclusion Criteria
  • low back pain caused by a known malignant disease
  • neck pain caused by trauma
  • known rheumatic disorder
  • history or planned surgery of the spinal column of the low back in the next 6 months
  • known neurological symptoms e.g radicular symptoms because of prolapsed vertebral disc
  • regular intake of analgesics (>1x per week) because of additional diseases
  • intake of centrally acting analgesics
  • known severe acute or chronic disorder, that do not allow participation in the therapy
  • other known diseases, that do not allow participation in the therapy
  • known alcohol or substance abuse
  • no sufficient German language skills
  • current application for a benefit
  • participation in another clinical trial during six months before the study and parallel to the study
  • conducting regular relaxation techniques, mindfulness training or meditation six weeks before the study or planned in the next 6 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
relaxationRelaxation exerciseParticipants allocated to the relaxation group will apply daily but at least five days a week a 15-minutes relaxation exercise, guided by a smartphone application (App). On a daily basis, participants can select one out of the three exercises (guided imagery, mindfulness based training, autogenic training) which they want to apply
Usual care waiting listususal carePatients allocated to the usual care waiting list group will continue with their usual care without receiving any additional therapy
Primary Outcome Measures
NameTimeMethod
Primary outcome is the mean pain intensity over 3 months measured by the daily pain intensity on the Numeric rating scale (NRS)3 months
Secondary Outcome Measures
NameTimeMethod
Pain acceptance3 and 6 months

German version of Chronic Pain Acceptance Questionnaire

Stress3 and 6 months

NRS

Suspected adverse reaction3 and 6 months
medication intake3 and 6 months
Mean pain intensity measured by the daily pain intensity on the NRS6 months
Mean pain intensity measured weekly as the average pain intensity of the last seven days on a NRS3 and 6 months
Number of Serious adverse event3 and 6 months
Number of sick leave days3 and 6 months

Trial Locations

Locations (1)

Charité Universitätsmedizin Berlin Berlin, Germany

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath